Journal Logo

Most Popular Articles

Association of SGLT2 Inhibitors With Risk of Atrial Fibrillation and Stroke in Patients With and Without Type 2 Diabetes: A Systemic Review and Meta-Analysis of Randomized Controlled Trials

Zheng, Ru-Jie; Wang, Yue; Tang, Jun-Nan; More

Journal of Cardiovascular Pharmacology. 79(2):e145-e152, February 2022.

Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients

Russo, Vincenzo; Ammendola, Ernesto; Gasperetti, Alessio; More

Journal of Cardiovascular Pharmacology. 79(4):472-478, April 2022.

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice

Guarracino, Fabio; Heringlake, Matthias; Cholley, Bernard; More

Journal of Cardiovascular Pharmacology. 71(1):1-9, January 2018.

Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

Papp, Zoltán; Agostoni, Piergiuseppe; Alvarez, Julian; More

Journal of Cardiovascular Pharmacology. 76(1):4-22, July 2020.

Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II–III Systolic Heart Failure

Wohlford, George F.; Van Tassell, Benjamin W.; Billingsley, Hayley E.; More

Journal of Cardiovascular Pharmacology. 77(1):49-60, January 2021.

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications

Altenberger, Johann; Gustafsson, Finn; Harjola, Veli-Pekka; More

Journal of Cardiovascular Pharmacology. 71(3):129-136, March 2018.

Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper

Herpain, Antoine; Bouchez, Stefaan; Girardis, Massimo; More

Journal of Cardiovascular Pharmacology. 73(1):3-14, January 2019.

The NLRP3 Inflammasome Inhibitor, OLT1177 (Dapansutrile), Reduces Infarct Size and Preserves Contractile Function After Ischemia Reperfusion Injury in the Mouse

Toldo, Stefano; Mauro, Adolfo Gabriele; Cutter, Zachary; More

Journal of Cardiovascular Pharmacology. 73(4):215-222, April 2019.

Safety and Efficacy of the Combination of Sacubitril/Valsartan and SGLT2i in HFrEF Patients (SECSI Registry)

Jiménez-Blanco Bravo, Marta; Valle, Alfonso; Gayán Ordás, Jara; More

Journal of Cardiovascular Pharmacology. 78(5):e662-e668, November 2021.

Amlodipine Reduces the Antimigratory Effect of Diclofenac in Spontaneously Hypertensive Rats

Rodrigues, Stephen Fernandes; dosSantos, Rosangela Aparecida; de Oliveira, Maria Aparecida; More

Journal of Cardiovascular Pharmacology. 51(5):492-504, May 2008.

Effect of DLT-SML on Chronic Stable Angina Through Ameliorating Inflammation, Correcting Dyslipidemia, and Regulating Gut Microbiota

Zhao, Xin; Chen, Yao; Li, Lin; More

Journal of Cardiovascular Pharmacology. 77(4):458-469, April 2021.

Paullinia pinnata Extracts Rich in Polyphenols Promote Vascular Relaxation via Endothelium-dependent Mechanisms

Zamble, Alexis; Carpentier, Marie; Kandoussi, Abdelmejid; More

Journal of Cardiovascular Pharmacology. 47(4):599-608, April 2006.

The Use of Voltage Sensitive Dye di-4-ANEPPS and Video-Based Contractility Measurements to Assess Drug Effects on Excitation–Contraction Coupling in Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes

Hortigon-Vinagre, Maria Pura; Zamora, Victor; Burton, Francis L.; More

Journal of Cardiovascular Pharmacology. 77(3):280-290, March 2021.

Influence of CYP2D6 Genotype on Metoprolol Plasma Concentration and β-Adrenergic Inhibition During Long-Term Treatment: A Comparison With Bisoprolol

Nozawa, Takashi; Taguchi, Masato; Tahara, Katsutoshi; More

Journal of Cardiovascular Pharmacology. 46(5):713-720, November 2005.

Intermittent Optogenetic Tachypacing of Atrial Engineered Heart Tissue Induces Only Limited Electrical Remodelling

Lemoine, Marc D.; Lemme, Marta; Ulmer, Bärbel M.; More

Journal of Cardiovascular Pharmacology. 77(3):291-299, March 2021.

Show: